ArticleArab journal of urology2026
Early continence assessment in retzius sparing robot Assisted radical prostatectomy using CMR versius® robotic surgical system.
Article in Arab journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Retzius-sparingrobot-assisted radical prostatectomy (RS-RARP) has been shown to significantlyimprove postoperative continence outcomes. Traditionally, this technique isperformed using the Da Vinci® Surgical System. To evaluatealternative robotic systems, we conducted RS-RARP procedures using the Versius® robotic surgical system. This report presents the functional outcomes of ourinitial experience and contributes to the growing body of evidence supportingthe feasibility and efficacy of the Versius® roboticsurgical system in RS-RARP. Methods: This prospective,non-randomized observational study included 50 patients who underwent RS-RARPusing the Versius® robotic surgical system with four bedside units.Surgeries were performed at Cairo University Hospitals (King Fahd Unit) and theRobosurge Center, Cleopatra Hospital Group (CHG) S.A.E. Cairo, Egypt, betweenDecember 2023 and August 2024. The procedure began with a horizontal incisionin the posterior peritoneum. The vasa deferentia were identified and transectedbilaterally. Seminal vesicles were mobilized and dissected after vascularcontrol. Denonvilliers' fascia was incised to develop the posterior planetoward the prostate-urethral junction. Prostatic pedicles were ligated anddivided, followed by lateral dissection to the apex and exposure of the dorsalvein complex. The bladder neck was sharply dissected. Anterior dissection wasperformed while preserving the detrusor and anterior pubovesical complex Urethrovesical anastomosis wascompleted using two 3-0 V-Loc™ sutures. Results: Earlycontinence - defined as use of 0-1 safety pad/day - was achieved in 90% ofpatients, rising to 96% at 6 months. An IIEF-5 score ≥17 was reported in 32% ofpatients at 1, 3, and 6 months postoperatively. The mean operative time was192.9 ± 7.5 minutes, with a mean prostate volume of 51.9 ± 15.9 grams and meanestimated blood loss of 82 mL. The average hospital stay was 2 days, andcatheter removal occurred after a mean of 7 days. Complications occurred in 10%of cases ( Conclusions: RS-RARP using the Versius® robotic surgical system is feasible and demonstrates favorable early outcomes in terms of continence,potency, and oncological safety. Further studies with larger cohorts andextended follow-up are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.